Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01037309
Show Display Options
Download search resultsDownload the search results for:
NCT01037309 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: PRO044 SC;   Drug: PRO044 IV

Study has passed its completion date and status has not been verified in more than two years.